- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 75
Blade to get a slice of Nasdaq action
Johns Hopkins spinout Blade Therapeutics has agreed to a reverse merger that will net it $24.3m in Pipe financing from backers including Osage University Partners.
Nov 11, 2021Daily deal net: November 11, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Nov 11, 2021Alcon advances to $475m Ivantis acquisition
Novartis eyecare subsidiary Alcon has agreed to acquire the Institut Mérieux, Ascension Health and MemorialCare Health System-backed MIGS technology provider.
Nov 11, 2021Entrada Therapeutics enters Nasdaq
The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.
Nov 11, 2021Arbor Bio harbours $215m
Vertex Pharmaceuticals and Illumina Ventures both contributed to a round that increased the genetic therapeutics developer's total funding to over $300m.
Nov 11, 2021Egle Therapeutics lands series A funding
Takeda Ventures was among the participants in a $46.5m round closed nearly a year after its parent company launched a partnership with the Institut Curie spinout.
Nov 11, 2021Jianhai Technology slides to series B-plus round
The health monitoring software provider, which counts iFlytek as an investor, has received $78.2m in a round led by Huaxing Growth Capital.
Nov 11, 2021Daily Deal Round Up: November 10, 2021
Capgemini, Salesforce and ServiceNow helped visual commerce platform developer Threekit net $35m while Tencent led a $26m round for UGC management software provider Mod.io.
Nov 10, 2021PharmEasy fishes for $842m in IPO
Multicorporate-backed online pharmacy operator API Holdings has filed for an offering that will not involve its shareholders selling their stakes.
Nov 10, 2021Daily Deal Round Up: November 9, 2021
DivcoWest, JLL and Allegion combined in a $60m round for workplace data platform developer VergeSense while Sanofi committed up to $60m to ocular therapeutics developer Gyroscope.
Nov 9, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


